A patient wearing a continuous glucose monitor and reading the results on a smartphone while holding a smart insulin pen

Biosensors are used in a growing number of smart medical devices, such as Medtronic’s InPen System with Guardian Connect continuous glucose monitor (pictured) [Photo courtesy of Medtronic]

Intricon today said it has launched a new Biosensors Center of Excellence focused exclusively on medical devices.

The St. Paul, Minnesota-based medical device developer and manufacturer said the center of excellence combines Intricon’s biosensor device expertise and capabilities into a vertically integrated business unit focused solely on bringing biosensor medical devices to market.

A portrait of Intricon CEO Scott Longval

Intricon CEO Scott Longval [Photo courtesy of Intricon]

“OEMs and startups need an approach like this because there are important intricacies in creating medical biosensor devices versus consumer biosensor products,” Intricon CEO Scott Longval said in a news release. “There’s a mass movement toward biosensors for medical applications, such as hospital at home and remote patient monitoring. Creating and commercializing first- and next-generation medical biosensor devices are more complex than ever and must happen at scale and cost profile to meet the demands of these exploding use cases.”

Longval cited the company’s four decades of experience in wearable medical biosensor devices and Intricon’s early innovations in hearing aids. Intricon said it is also the primary developer and manufacturer of wearable glucose monitoring devices for Medtronic, the world’s largest medical device company.

Intricon plans to expand its team of biosensors experts with key hires this year. The company said its biosensors team already has deep expertise in high-density microelectronics, miniaturization, ultra-low power, miniature molding, firmware development and wireless communication, including Bluetooth and Bluetooth Low Energy technology.

“We’re responding to the industry, which needs deep expertise in the many complex capabilities required to successfully compete in this quickly emerging device category,” Intricon Chief Commercial and Technology Officer Dave Liebl said in the release.

July 2022: Intricon names new chief commercial, technology and financial officers

Intricon’s other sensor-driven expertise is in developing and manufacturing medical devices that use electromagnetic (EM) navigation. The company said it has proprietary modeling and engineering systems to design and produce micro-coils that meet electromagnetic goals such as induction, resistance, sensitivity and localization performance.

MDO Contributors Network posts from Intricon: